80 related articles for article (PubMed ID: 23234641)
1. Comparative evaluation of two dye probes in the rat everted gut sac model for unambiguous classification of P-gp substrate and inhibitor.
Perrone MG; Inglese C; Berardi F; Leopoldo M; Perrone R; Colabufo NA
J Pharmacol Toxicol Methods; 2013; 67(1):5-8. PubMed ID: 23234641
[TBL] [Abstract][Full Text] [Related]
2. The effects of PLGA microparticles on intestinal absorption of p-glycoprotein substrate using the everted rat intestinal sac model.
Derakhshandeh K; Hosseinalizadeh A; Nikmohammadi M
Arch Pharm Res; 2011 Nov; 34(11):1989-97. PubMed ID: 22139699
[TBL] [Abstract][Full Text] [Related]
3. Acetaminophen inhibits intestinal p-glycoprotein transport activity.
Novak A; Carpini GD; Ruiz ML; Luquita MG; Rubio MC; Mottino AD; Ghanem CI
J Pharm Sci; 2013 Oct; 102(10):3830-7. PubMed ID: 23897240
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments.
Ballent M; Lifschitz A; Virkel G; Sallovitz J; Lanusse C
Drug Metab Dispos; 2006 Mar; 34(3):457-63. PubMed ID: 16381664
[TBL] [Abstract][Full Text] [Related]
5. The metabolism of midazolam and comparison with other CYP enzyme substrates during intestinal absorption: in vitro studies with rat everted gut sacs.
Arellano C; Philibert C; Vachoux C; Woodley J; Houin G
J Pharm Pharm Sci; 2007; 10(1):26-36. PubMed ID: 17498391
[TBL] [Abstract][Full Text] [Related]
6. Absorption enhancement studies of clopidogrel hydrogen sulphate in rat everted gut sacs.
Lassoued MA; Sfar S; Bouraoui A; Khemiss F
J Pharm Pharmacol; 2012 Apr; 64(4):541-52. PubMed ID: 22420660
[TBL] [Abstract][Full Text] [Related]
7. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
[TBL] [Abstract][Full Text] [Related]
8. Gender-related differences on P-glycoprotein-mediated drug intestinal transport in rats.
Mariana B; Adrián L; Guillermo V; Juan S; Laura M; Carlos L
J Pharm Pharmacol; 2011 May; 63(5):619-26. PubMed ID: 21492163
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique.
Fortuna A; Alves G; Falcão A; Soares-da-Silva P
Epilepsia; 2012 Mar; 53(3):529-38. PubMed ID: 22372629
[TBL] [Abstract][Full Text] [Related]
10. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
[TBL] [Abstract][Full Text] [Related]
11. Everted rat intestinal sacs: a new model for the quantitation of P-glycoprotein mediated-efflux of anticancer agents.
Carreño-Gómez B; Duncan R
Anticancer Res; 2000; 20(5A):3157-61. PubMed ID: 11062737
[TBL] [Abstract][Full Text] [Related]
12. Kinetic characterization of P-glycoprotein-mediated efflux of rhodamine 6G in the intact rabbit lung.
Roerig DL; Audi SH; Ahlf SB
Drug Metab Dispos; 2004 Sep; 32(9):953-8. PubMed ID: 15319336
[TBL] [Abstract][Full Text] [Related]
13. A simplified protocol employing elacridar in rodents: a screening model in drug discovery to assess P-gp mediated efflux at the blood brain barrier.
Kallem R; Kulkarni CP; Patel D; Thakur M; Sinz M; Singh SP; Mahammad SS; Mandlekar S
Drug Metab Lett; 2012 Jun; 6(2):134-44. PubMed ID: 23061481
[TBL] [Abstract][Full Text] [Related]
14. P-gp activity and inhibition in the different regions of human intestine ex vivo.
Li M; de Graaf IA; de Jager MH; Groothuis GM
Biopharm Drug Dispos; 2017 Mar; 38(2):127-138. PubMed ID: 27757966
[TBL] [Abstract][Full Text] [Related]
15. Measurement of basal, substrate induced and total P-glycoprotein activity in bronchoalveolar lavage T-cell subsets.
Donnenberg VS; Wilson JW; Burckart GJ; Zeevi A; Iacono A; Donnenberg AD
Cytometry A; 2004 Feb; 57(2):75-85. PubMed ID: 14750128
[TBL] [Abstract][Full Text] [Related]
16. P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in mice.
Meredith JE; Thompson LA; Toyn JH; Marcin L; Barten DM; Marcinkeviciene J; Kopcho L; Kim Y; Lin A; Guss V; Burton C; Iben L; Polson C; Cantone J; Ford M; Drexler D; Fiedler T; Lentz KA; Grace JE; Kolb J; Corsa J; Pierdomenico M; Jones K; Olson RE; Macor JE; Albright CF
J Pharmacol Exp Ther; 2008 Aug; 326(2):502-13. PubMed ID: 18499745
[TBL] [Abstract][Full Text] [Related]
17. Quantitative investigation of the impact of P-glycoprotein inhibition on drug transport across blood-brain barrier in rats.
Sugimoto H; Hirabayashi H; Kimura Y; Furuta A; Amano N; Moriwaki T
Drug Metab Dispos; 2011 Jan; 39(1):8-14. PubMed ID: 20962062
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclosporine on drug transport and pharmacokinetics of nifedipine.
Dorababu M; Nishimura A; Prabha T; Naruhashi K; Sugioka N; Takada K; Shibata N
Biomed Pharmacother; 2009 Nov; 63(9):697-702. PubMed ID: 19819100
[TBL] [Abstract][Full Text] [Related]
19. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of P-glycoprotein expression in small intestine under chronic serotonin-depleted conditions in rats.
Hiraoka H; Kimura N; Furukawa Y; Ogawara K; Kimura T; Higaki K
J Pharmacol Exp Ther; 2005 Jan; 312(1):248-55. PubMed ID: 15466248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
